BioCentury
ARTICLE | Company News

Management tracks: Five Prime, CytoSen

October 24, 2017 8:22 PM UTC

Cancer play Five Prime Therapeutics Inc. (NASDAQ:FPRX) promoted Aron Knickerbocker to president and CEO from COO, effective Jan. 1, 2018. He succeeds Lewis Williams, who will become executive chairman.

Cell therapy company CytoSen Therapeutics Inc. (Orlando, Fla.) named Jak Knowles CEO. He was managing director of CureDuchenne Ventures and VP of medical and scientific affairs at CureDuchenne (Newport Beach, Calif.)...